SUSAN JENKINS: Open Payments
NPI 1518087139 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 22 payments from 11 companies in 2025. Trend: 2023 $437 · 2024 $260 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Novo Nordisk Inc | 4 | $92 |
| ABBVIE INC. | 2 | $58 |
| Alkermes, Inc. | 2 | $56 |
| Lilly USA, LLC | 2 | $54 |
| Exact Sciences Corporation | 1 | $29 |
| Indivior Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Braeburn Inc. | 1 | $21 |
Products named: FARXIGA, VRAYLAR, VIVITROL, MOUNJARO, Wegovy, AIRSUPRA, The Cologuard Plus Collection Kit, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
